Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Fay

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Blood|February 15, 1990
The treatment of progressive non-Hodgkin's lymphoma with intensive chemoradiotherapy and autologous marrow transplantationG L Phillips, J W Fay, R H Herzig, et al.
Blood|April 15, 1996
FK506 (Tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogenic bone marrow transplantationJ W Fay, J R Wingard, J H Antin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 1998
Safeguarding the administration of high-dose chemotherapy: a national practice survey by the American Society for Blood and Marrow TransplantationC S Chen, K Seidel, J O Armitage, et al.
Blood|September 9, 2000
Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donorsR A Nash, J H Antin, C Karanes, et al.
Blood|November 1, 1996
FK506 in combination with methotrexate for the prevention of graft-versus-host disease after marrow transplantation from matched unrelated donorsR A Nash, L A Piñeiro, R Storb, et al.
Blood|February 15, 1996
Biological effects of recombinant human granulocyte colony-stimulating factor in patients with untreated acute myeloid leukemiaM R Baer, S H Bernstein, V L Brunetto, et al.
Blood|August 15, 1996
A phase I study of bolus versus continuous infusion of the anti-CD19 immunotoxin, IgG-HD37-dgA, in patients with B-cell lymphomaM J Stone, E A Sausville, J W Fay, et al.
Leukemia & Lymphoma|October 8, 1999
Protracted results of dose-intensive therapy using cyclophosphamide, carmustine, and continuous infusion etoposide with autologous stem cell support in patients with relapse or refractory Hodgkin's disease: a phase II study from the North American Marrow Transplant GroupD R Fleming, S N Wolff, J W Fay, et al.
Blood|May 23, 1998
A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantationS H Bernstein, A P Nademanee, J M Vose, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North AmericaK H Antman, P A Rowlings, W P Vaughan, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Blood|February 15, 1990
The treatment of progressive non-Hodgkin's lymphoma with intensive chemoradiotherapy and autologous marrow transplantationG L Phillips, J W Fay, R H Herzig, et al.
Blood|April 15, 1996
FK506 (Tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogenic bone marrow transplantationJ W Fay, J R Wingard, J H Antin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 1998
Safeguarding the administration of high-dose chemotherapy: a national practice survey by the American Society for Blood and Marrow TransplantationC S Chen, K Seidel, J O Armitage, et al.
Blood|September 9, 2000
Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donorsR A Nash, J H Antin, C Karanes, et al.
Blood|November 1, 1996
FK506 in combination with methotrexate for the prevention of graft-versus-host disease after marrow transplantation from matched unrelated donorsR A Nash, L A Piñeiro, R Storb, et al.
Blood|February 15, 1996
Biological effects of recombinant human granulocyte colony-stimulating factor in patients with untreated acute myeloid leukemiaM R Baer, S H Bernstein, V L Brunetto, et al.
Blood|August 15, 1996
A phase I study of bolus versus continuous infusion of the anti-CD19 immunotoxin, IgG-HD37-dgA, in patients with B-cell lymphomaM J Stone, E A Sausville, J W Fay, et al.
Leukemia & Lymphoma|October 8, 1999
Protracted results of dose-intensive therapy using cyclophosphamide, carmustine, and continuous infusion etoposide with autologous stem cell support in patients with relapse or refractory Hodgkin's disease: a phase II study from the North American Marrow Transplant GroupD R Fleming, S N Wolff, J W Fay, et al.
Blood|May 23, 1998
A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantationS H Bernstein, A P Nademanee, J M Vose, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North AmericaK H Antman, P A Rowlings, W P Vaughan, et al.
Pageof 6